Wohlschlegel
Wohlschlegel
- Founder and General Manager, be executive GmbH
- General Manager, Merck Serono GmbH, Germany
- Senior VP Europe, Merck KGaA
- Managing Director & General Manager, Merck s.a. Portugal
Milz
Milz
In the industry since 1991, in the company from 1991 to 1996 and again since 1997:
- Director Market Access (UCB Pharma GmbH)
- Director Marketing (Schwarz Pharma Deutschland GmbH)
- Product Manager & Head of Marketing Vascular (Schwarz Pharma Deutschland GmbH)
Wiedenfels
Wiedenfels
On the Supervisory Board since: April 2021
Elected until 2027
- Lawyer and serial entrepreneur
- Chief Executive Officer, Perspix Biotech GmbH
- Member of the Executive Board, BioMedion AG
Elbracht
Elbracht
On the Supervisory Board since: April 2021
Elected until: 2027
-
Management Consultant,
-
Vice President Global Business Services Finance, UCB Pharma S.A.,
-
Chief Financial Officer, Schwarz Pharma,
-
Audit Manager, Deloitte GmbH
Picciolo-Lehrke
Picciolo-Lehrke
On the Supervisory Board since: May 2022
Elected until: 2027
-
Since 2008 Head of Global Business Development Neurology at UCB Pharma GmbH,
-
From 2006 Member of the Corporate Business Development at UCB Pharma GmbH,
-
From 2005 Activity for the BD & Licensing Team of Schwarz Pharma AG
Hadzic
Hadzic
On the Supervisory Board since: April 2021
Elected until: 2027
-
Since 2004: Founding partner, Paragon Partners,
-
Partner, Triton Partners,
-
Partner, Drueker & Co.,
-
Arthur Andersen LLP
Bettinger
Bettinger
On the Supervisory Board since: April 2021
Elected until: 2027
- Since 2014: Paragon Partners
- Head of Strategy/Data/Project Management, CLIQZ
- McKinsey & Company
- Siemens AG